AU2006319987B2 — Precursor compound of radioactive halogen labeled organic compound
Assigned to Nihon Medi Physics Co Ltd · Expires 2012-09-06 · 14y expired
What this patent protects
[PROBLEMS] To provide a novel amino acid organic compound that can be used as a labeled precursor compound of [F]FACBC and other radioactive halogen labeled amino acid compounds, and that ensures freedom from methanol residue in the produced radioactive halogen labeled amino acid…
USPTO Abstract
[PROBLEMS] To provide a novel amino acid organic compound that can be used as a labeled precursor compound of [F]FACBC and other radioactive halogen labeled amino acid compounds, and that ensures freedom from methanol residue in the produced radioactive halogen labeled amino acid compound. [MEANS FOR SOLVING PROBLEMS] Compounds of the formula: (1) wherein n is 0 or an integer of 1 to 4; R is an ethyl substituent, 1-propyl substituent or isopropyl substituent; X is a halogen substituent or group of the formula -OR in which R is a linear or branched-chain C-C haloalkylsulfonate substituent, C-C trialkylstannyl substituent, fluorosulfonate substituent or aromatic sulfonate substituent; and R is a protective group.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.